Stocks · News reference
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire’s $330M investment. Liquidia and Verastem also posted strong gains.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Equal-Weight on Halozyme Therapeutics, Raises Price Target to $110
Relevant Gold Corp. Receives Regulatory Approval for Expanded Drilling at Lewiston Project
Relevant Gold Corp. has secured approval from the U.S. Bureau of Land Management and the Wyoming Department of Environmental Quality for its Plan of Operations and Drill Notice, enabling expanded exploration drilling at its Lewiston Project.
Bending Spoons to announce Q3 2026 results
Bending Spoons S.p.A. (Nasdaq: BSP) announced it will release Q3 2026 financial results on November 20, 2026, followed by a conference call and webcast at 8:00 am ET. The company, which specializes in acquiring and transforming digital businesses, continues its strategy of operational excellence and sustainable earnings expansion through acquisitions.
FDA Grants Accelerated Approval to RYBREVANT FASPRO™ for Head and Neck Squamous Cell Carcinoma
The FDA has granted accelerated approval to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), which utilizes Halozyme's ENHANZE® drug delivery technology, for the treatment of head and neck squamous cell carcinoma.
Halozyme Therapeutics Reports Q3 2026 Financial Results and Raises Full-Year Guidance
Halozyme Therapeutics reported strong third-quarter 2026 financial results, featuring a 39% year-over-year revenue increase and an upward revision to its full-year 2026 financial outlook.